$OMDA

Gracey Craig sold $25K of OMDA

Gracey Craig (Chief Accounting Officer) sold 1,041 shares of Omada Health, Inc. (OMDA) at $24.00 on 2026-07-13 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gracey Craig
Published Jul 15, 2026, 8:33 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 15, 2026, 8:37 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

The disclosure confirms an open-market sale of 1,041 shares at $24.00, totaling $24,984, under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale for sentiment monitoring, but the 10b5-1 structure and small size reduce fundamental impact.

03

What to watch

The article provides no context on total planned sales, remaining 10b5-1 schedule, or whether the officer sold for diversification or tax reasons.

Relevance 2/10Novelty 2/10Timing: Filed on 2026-07-15 after-hours, reflecting a 2026-07-13 sale.

Background

This is an SEC Form 4 insider transaction for Omada Health, Inc., reported by Chief Accounting Officer Gracey Craig.

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

Omada Health insider Gracey Craig sold 1,041 shares at $24.00 on 2026-07-13 under a pre-arranged 10b5-1 plan.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-only and typically fades.

Evidence & confidence

The filing is a Form 4 insider sale, explicitly tied to a pre-arranged 10b5-1 plan, and the disclosed transaction size is small relative to company-level fundamentals.

Market effects

No clear read-across to the digital health or care-delivery sector from a single small 10b5-1 sale.

None.

None.

Counterpoint

Even 10b5-1 sales can coincide with internal expectations, so some traders may briefly re-rate sentiment if they view the sale as risk-reducing.

Key entities

  • Omada Health, Inc.

    US-listed company whose insider sale is disclosed on Form 4.

  • Gracey Craig

    Chief Accounting Officer who executed the reported open-market sale.

  • 10b5-1 plan

    Pre-arranged plan intended to reduce timing-based inference from insider trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OMDAHighAI 9/10

Omada Health (OMDA) Q2 2026 Earnings Call Transcript

Omada Health (OMDA) reported Q2 2026 revenue of $88 million, up 43% year over year, with GAAP gross margin of 73% and GAAP net income of $5 million. Adjusted EBITDA was $11 million. The company raised full-year revenue guidance to $334 million to $340 million and adjusted EBITDA to $21 million to $27 million, citing member growth and lower cost to serve.

$OMDAHigh

Omada Health, Inc. (OMDA): Results of Operations and Financial Condition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Become Executive Chair and Wei-Li Shao to Become Ch